Latest Insider Transactions at Healthpeak Properties, Inc. (PEAK)
This section provides a real-time view of insider transactions for Healthpeak Properties, Inc. (PEAK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HEALTHPEAK PROPERTIES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HEALTHPEAK PROPERTIES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2024
|
John T Thomas Director |
SELL
Bona fide gift
|
Direct |
48,775
-5.77%
|
-
|
|
Sep 04
2024
|
Thomas Klaritch COO |
SELL
Bona fide gift
|
Direct |
6,488
-1.93%
|
-
|
|
Apr 26
2024
|
Katherine M Sandstrom Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+17.55%
|
-
|
|
Apr 26
2024
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+7.27%
|
-
|
|
Apr 26
2024
|
Richard A. Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+13.95%
|
-
|
|
Apr 26
2024
|
R Kent Griffin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+12.06%
|
-
|
|
Apr 26
2024
|
Pamela Shelley Kessler Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+19.45%
|
-
|
|
Apr 26
2024
|
Sara Grootwassink Lewis Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+20.97%
|
-
|
|
Apr 26
2024
|
Ava Lias Booker Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+32.48%
|
-
|
|
Apr 26
2024
|
Brian G. Cartwright Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+13.18%
|
-
|
|
Apr 26
2024
|
James B. Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+35.02%
|
-
|
|
Apr 03
2024
|
John T Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,763
+2.51%
|
-
|
|
Mar 04
2024
|
Sara Grootwassink Lewis Director |
BUY
Open market or private purchase
|
Indirect |
18,000
+45.0%
|
$288,000
$16.71 P/Share
|
|
Feb 15
2024
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
535
-3.21%
|
$8,560
$16.86 P/Share
|
|
Feb 12
2024
|
Scott M Brinker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,980
-2.48%
|
$84,660
$17.34 P/Share
|
|
Feb 12
2024
|
Scott R Bohn CDO and Head of Lab |
SELL
Payment of exercise price or tax liability
|
Direct |
2,633
-12.39%
|
$44,761
$17.34 P/Share
|
|
Feb 12
2024
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-2.53%
|
$7,361
$17.34 P/Share
|
|
Feb 10
2024
|
Scott M Brinker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,626
-2.72%
|
$95,642
$17.34 P/Share
|
|
Feb 10
2024
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
440
-2.51%
|
$7,480
$17.34 P/Share
|
|
Feb 02
2024
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
227
-1.28%
|
$4,086
$18.82 P/Share
|
|
Feb 01
2024
|
Lisa A Alonso EVP and Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,328
+8.33%
|
-
|
|
Oct 03
2023
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,020
-6.6%
|
$17,340
$17.81 P/Share
|
|
Apr 28
2023
|
James B. Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,193
+50.0%
|
-
|
|
Apr 28
2023
|
Sara Grootwassink Lewis Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,193
+23.61%
|
-
|
|
Apr 28
2023
|
Brian G. Cartwright Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,193
+13.28%
|
-
|
|
Apr 28
2023
|
David Henry Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,193
+8.8%
|
-
|
|
Apr 28
2023
|
Christine Garvey Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,193
+50.0%
|
-
|
|
Apr 28
2023
|
R Kent Griffin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,193
+11.98%
|
-
|
|
Apr 28
2023
|
Katherine M Sandstrom Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,193
+18.79%
|
-
|
|
Mar 17
2023
|
Thomas Klaritch COO |
SELL
Bona fide gift
|
Direct |
7,100
-2.06%
|
-
|
|
Mar 15
2023
|
Sara Grootwassink Lewis Director |
BUY
Open market or private purchase
|
Indirect |
4,000
+50.0%
|
$84,000
$21.43 P/Share
|
|
Mar 07
2023
|
Thomas Klaritch COO |
BUY
Open market or private purchase
|
Direct |
1,517
+0.44%
|
$34,891
$23.21 P/Share
|
|
Mar 02
2023
|
Scott M Brinker President and CEO |
BUY
Open market or private purchase
|
Direct |
16,300
+7.32%
|
$374,900
$23.63 P/Share
|
|
Feb 22
2023
|
Christine Garvey Director |
SELL
Open market or private sale
|
Indirect |
1,200
-5.04%
|
$30,000
$25.45 P/Share
|
|
Feb 15
2023
|
Scott M Brinker President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
91,200
-32.41%
|
-
|
|
Feb 15
2023
|
Shawn G Johnston EVP and CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,672
-12.59%
|
-
|
|
Feb 15
2023
|
Thomas Klaritch COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,899
-5.23%
|
-
|
|
Feb 15
2023
|
Adam G Mabry CIO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
53,151
-93.44%
|
-
|
|
Feb 15
2023
|
Jeffrey H Miller General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,760
-28.99%
|
-
|
|
Feb 15
2023
|
Ankit B. Patadia EVP and Treasurer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,373
-57.79%
|
-
|
|
Feb 15
2023
|
Peter A Scott CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
38,724
-19.07%
|
-
|
|
Feb 15
2023
|
Scott R Bohn CDO and Head of Lab |
SELL
Sale (or disposition) back to the issuer
|
Direct |
36,301
-63.07%
|
-
|
|
Feb 14
2023
|
Thomas Klaritch COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,119
-0.58%
|
$55,094
$26.49 P/Share
|
|
Feb 14
2023
|
Adam G Mabry CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-2.08%
|
$31,356
$26.49 P/Share
|
|
Feb 14
2023
|
Peter A Scott CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,641
-1.28%
|
$68,666
$26.49 P/Share
|
|
Feb 14
2023
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
286
-1.82%
|
$7,436
$26.49 P/Share
|
|
Feb 14
2023
|
Shawn G Johnston EVP and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-1.7%
|
$20,254
$26.49 P/Share
|
|
Feb 14
2023
|
Jeffrey H Miller General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
706
-1.58%
|
$18,356
$26.49 P/Share
|
|
Feb 14
2023
|
Ankit B. Patadia EVP and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
887
-5.77%
|
$23,062
$26.49 P/Share
|
|
Feb 14
2023
|
Scott R Bohn CDO and Head of Lab |
SELL
Payment of exercise price or tax liability
|
Direct |
893
-1.53%
|
$23,218
$26.49 P/Share
|